AI-enabled imaging of the retina’s network of veins and arteries can accurately predict cardiovascular disease and death, without the need for blood tests or blood pressure measurement, finds research published online in the British Journal of Ophthalmology.
While several risk frameworks exist, these aren’t always able to accurately identify those who will go on to develop or die of circulatory diseases, say the researchers. Previously published research indicates that the width of the tiny veins and arteries (arterioles and venules) of the retina—the part of the eye that receives and organizes visual information—may provide an accurate early indicator of circulatory disease. But it’s not clear whether these findings apply consistently and equally to men and women.
So the researchers developed a fully automated artificial intelligence (AI)- enabled algorithm (QUantitative Analysis of Retinal vessels Topology and siZe, or QUARTZ for short) to develop models to assess the potential of retinal vasculature imaging plus known risk factors to predict vascular health and death.
They applied QUARTZ to retinal images from 88,052 UK Biobank participants aged 40-69, looking specifically at the width, vessel area, and degree of curviness (tortuosity) of the arterioles and venules in the retina to develop prediction models for stroke, heart attack, and death from circulatory disease.
They subsequently applied these models to the retinal images of 7411 participants, aged 48-92, of the European Prospective Investigation into Cancer (EPIC)-Norfolk study. The performance of QUARTZ was compared with the widely used Framingham Risk Scores framework, both separately and jointly.
In men, arteriolar and venular width, tortuosity, and width variation emerged as important predictors of death from circulatory disease. In women, arteriolar and venular area and width and venular tortuosity and width variation contributed to risk prediction.
The predictive impact of retinal vasculature on circulatory disease death interacted with smoking, drugs to treat high blood pressure, and previous heart attack. Overall, these predictive models, based on age, smoking, medical history and retinal vasculature, captured between half and two thirds of circulatory disease deaths in those most at risk.
Retinal vasculature models captured about 5% more cases of stroke in UK Biobank men and 8% more cases in UK Biobank women and 3% more cases among EPIC-Norfolk men most at risk, but nearly 2% fewer cases among EPIC-Norfolk women. Framingham Risk Scores captured more cases of heart attack among those most at risk.
Adding retinal vasculature to Framingham Risk Scores effected only marginal changes in the prediction of stroke or heart attack. But a simpler non-invasive risk score based on age, sex, smoking, medical history and retinal vasculature performed as well as the Framingham Risk Scores, and without the need for blood tests or blood pressure measurement, say the researchers.
They acknowledge that both groups of study participants have healthier lifestyles than other geographically similar middle-aged people, and that most are white. But this is the largest population-based study of retinal vasculature, and the prediction models were externally validated in a large number of people, they explain.
Retinal imaging is already common practice in the UK and the U.S., point out the researchers, who conclude, “AI-enabled vasculometry risk prediction is fully automated, low cost, non-invasive and has the potential for reaching a higher proportion of the population in the community because of ‘high street’ availability and because blood sampling or [blood pressure measurement] are not needed.”
They continue, “[Retinal vasculature] is a microvascular marker, hence offers better prediction for circulatory mortality and stroke compared with [heart attack] which is more macrovascular, except perhaps in women.
“In the general population it could be used as a non-contact form of systemic vascular health check, to triage those at medium-high risk of circulatory mortality for further clinical risk assessment and appropriate intervention.”
In the UK, for example, it could be included in the primary care NHS Health Check for those aged 41-74, they suggest.
In a linked editorial, Drs. Ify Mordi and Emanuele Trucco of the University of Dundee, Scotland, explain that the use of retinal vasculature changes to inform overall cardiovascular risk is “certainly attractive and intuitive,” but is yet to become part of routine clinical practice.
“Using retinal screening in this way would presumably require a significant increase in the number of ophthalmologists or otherwise trained assessors,” they suggest, and ask: Which specialty would take on responsibility for preventive treatment and the additional workload: ophthalmologists, cardiologists, or primary care practitioners?
“What is now needed is for ophthalmologists, cardiologists, primary care physicians and computer scientists to work together to design studies to determine whether using this information improves clinical outcome, and, if so, to work with regulatory bodies, scientific societies and healthcare systems to optimize clinical workflows and enable practical implementation in routine practice,” they conclude.
In a new study, scientists with the University of Florida have found that a combination of silver nanoparticles and antibiotics is effective against antibiotic-resistant bacteria. The researchers hope to turn this discovery into viable [...]
Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with [...]
According to a new study by researchers at Penn Medicine, ketamine, which is well-known as an anesthetic and is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if [...]
A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine [...]
An AI was tasked with creating proteins with anti-microbial properties. Researchers then created a subset of the proteins and found some did the job. An AI has designed anti-microbial proteins that were then tested [...]
Treating cancer with combinations of drugs can be more effective than using a single drug. However, figuring out the optimal combination of drugs, and making sure that all of the drugs reach the right [...]
By one unique metric, we could approach technological singularity by the end of this decade, if not sooner. A translation company developed a metric, Time to Edit (TTE), to calculate the time it takes for professional [...]
Phase transition in early universe changes strength of interaction between dark and normal matter. Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without [...]
Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of [...]
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The [...]
Using a mouse model, Japanese researchers unleash the likely mechanism of action of Actinidia arguta (sarunashi) juice on lung cancer development. Lung cancer is a leading cause of death in Japan and across the [...]
When used as wearable medical devices, stretchy, flexible gas sensors can identify health conditions or issues by detecting oxygen or carbon dioxide levels in the breath or sweat. They also are useful for monitoring [...]
Novel drugs, such as vaccines against covid-19, among others, are based on drug transport using nanoparticles. Whether this drug transport is negatively influenced by an accumulation of blood proteins on the nanoparticle’s surface was [...]
The costly lesson from COVID: why elimination should be the default global strategy for future pandemics
Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus. Epidemiological [...]
A predictive model has been developed that enables researchers to encode instructions for cells to execute. Scientists at the University of California, San Francisco (UCSF) and IBM Research have created a virtual library of thousands of “command sentences” [...]
It's "lights out" for antibiotic-resistant superbugs as next-generation light-activated nanotech proves it can eradicate some of the most notorious and potentially deadly bacteria in the world. Developed by the University of South Australia and [...]